{"skill":{"slug":"alnylam-pharma","displayName":"Alnylam Pharma","summary":"Alnylam Pharma pioneers RNAi therapeutics with three approved siRNA drugs for rare genetic and cardiovascular diseases using GalNAc delivery technology.","tags":{"latest":"1.0.0"},"stats":{"comments":0,"downloads":99,"installsAllTime":0,"installsCurrent":0,"stars":0,"versions":1},"createdAt":1778245497100,"updatedAt":1778492880688},"latestVersion":{"version":"1.0.0","createdAt":1778245497100,"changelog":"- 首发版本，介绍Alnylam Pharmaceuticals的基本情况、发展历史和核心业务。\n- 补充了公司在RNAi疗法领域的里程碑事件和多款已上市药物。\n- 罗列关键财务数据和商业合作信息，突出技术及数据壁垒。\n- 加入行业分析、适用场景和有趣事实，便于快速了解公司。","license":"MIT-0"},"metadata":null,"owner":{"handle":"hanxueyuan","userId":"s17eht14r6y7ztwaw37n96ka7583eghn","displayName":"hanxueyuan","image":"https://avatars.githubusercontent.com/u/16717383?v=4"},"moderation":null}